New hope for uncontrolled involuntary movements
NCT ID NCT07105111
Summary
This study is testing a medication called valbenazine for people with tardive dyskinesia (TD), which causes uncontrollable movements. It is for adults with TD who still have symptoms while taking a similar medication or after stopping one. The main goal is to see if switching to valbenazine helps reduce these involuntary movements over 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TARDIVE DYSKINESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neurocrine Clinical Site
RECRUITINGBryant, Arkansas, 72022, United States
-
Neurocrine Clinical Site
RECRUITINGFountain Valley, California, 92708, United States
-
Neurocrine Clinical Site
RECRUITINGOrange, California, 92866, United States
-
Neurocrine Clinical Site
RECRUITINGBonita Springs, Florida, 34134, United States
-
Neurocrine Clinical Site
RECRUITINGHialeah, Florida, 33012, United States
-
Neurocrine Clinical Site
RECRUITINGMiami, Florida, 33176, United States
-
Neurocrine Clinical Site
RECRUITINGTampa, Florida, 33629, United States
-
Neurocrine Clinical Site
RECRUITINGMarietta, Georgia, 30060, United States
Conditions
Explore the condition pages connected to this study.